Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $69.8700 (-8.34%) ($69.8700 - $69.8700) on Thu. Dec. 31, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 7.4% (three month average) | RSI | 57 | Latest Price | $69.8700(-8.34%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -3.1% a day on average for past five trading days. | Weekly Trend | EDIT advances 9.4% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(65%) IWO(61%) IWC(58%) IBUY(57%) IWM(56%) | Factors Impacting EDIT price | EDIT will decline at least -3.7% in a week (0% probabilities). VIXM(-32%) UUP(-15%) VXX(-13%) TBT(-7%) UNG(0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.7% (StdDev 7.4%) | Hourly BBV | -1.7 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $77.77(-10.16%) | 10 Day Moving Average | $76.38(-8.52%) | 20 Day Moving Average | $65.07(7.38%) | To recent high | -17.4% | To recent low | 158% | Market Cap | $4.339b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |